Breaking News Instant updates and real-time market news.

CUB

Cubic

$58.97

-2.035 (-3.34%)

05:07
11/30/18
11/30
05:07
11/30/18
05:07

Cubic upgraded to Overweight from Neutral at JPMorgan

JPMorgan analyst Mark Strouse upgraded Cubic Corp. to Overweight while lowering his price target for the shares to $73 from $75. The analyst cites valuation for the upgrade as he views the recent pullback in the stock as a buying opportunity.

  • 29

    Nov

CUB Cubic
$58.97

-2.035 (-3.34%)

11/16/18
NEED
11/16/18
UPGRADE
Target $80
NEED
Buy
Cubic upgraded to Buy from Hold at Needham
Needham analyst James Ricchiuti upgraded Cubic to Buy from Hold with a price target of $80 after its "solid" Q4 results. The analyst notes that the company's FY20 targets now appear to be "well within reach" following the 11% increase in its backlog during Q4 to a record $4.1B. Ricchiuti attributes the backlog increase in part to "another major award in its Transportation business" - a $394M contract in San Francisco. The analyst further cites Cubic's attractive valuation in his rating change, saying that the 15% sell-off in its stock price from the highs has put its enterprise value to out-year expected adjusted EBITDA multiple at less than 11-times.
11/16/18
ADAM
11/16/18
NO CHANGE
Target $78
ADAM
Buy
Cubic well positioned for longer-term upside, says Canaccord
Canaccord analyst Ken Herbert noted Cubic reported Q4 results that were in-line with expectations. The analyst believes the narrative on the company continues to be a transition to execution on its backlog and the potential for some top-line catalysts. He believes the company is well positioned as urban transportation evolves due to increased congestion, autonomous capabilities, and digital technologies. Herbert reiterated his Buy rating and $78 price target on Cubic shares.
08/09/18
ADAM
08/09/18
NO CHANGE
Target $78
ADAM
Buy
Cubic results provide increased confidence, says Canaccord
Canaccord analyst Ken Herbert said Cubic reported strong Q1 results which increased his confidence in the company's long-term goals. The analyst said the shares are reflecting increased confidence in the full-year 2018 results, and increased confidence in margin expansion and Goal 2020 opportunity. Herbert reiterated his Buy rating and raised his price target to $78 from $76 on Cubic shares.
06/14/18
ADAM
06/14/18
NO CHANGE
Target $76
ADAM
Buy
Cubic price target raised to $76 from $72 at Canaccord
Canaccord analyst Ken Herbert raised his price target on Cubic to $76 from $72 following its analyst day. The analyst cited the company's increase in its 2020 outlook for revenues and margins as well as incremental detail on the outlook by operating segment. Herbert reiterated his Buy rating on Cubic shares.

TODAY'S FREE FLY STORIES

CBWTF

Auxly Cannabis

$0.00

(0.00%)

07:33
11/22/19
11/22
07:33
11/22/19
07:33
Hot Stocks
Auxly says company 'ready to enter' Cannabis 2.0 market on first day of sales »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

, F

Ford

$8.72

-0.005 (-0.06%)

07:32
11/22/19
11/22
07:32
11/22/19
07:32
Recommendations
Tesla, Ford, General Motors analyst commentary  »

Tesla's $39,900…

TSLA

Tesla

F

Ford

$8.72

-0.005 (-0.06%)

GM

General Motors

$34.66

-0.6 (-1.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 09

    Dec

  • 04

    Feb

CTSH

Cognizant

$63.42

-0.09 (-0.14%)

07:32
11/22/19
11/22
07:32
11/22/19
07:32
Downgrade
Cognizant rating change  »

Cognizant downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMSY

HMS Holdings

$29.51

0.52 (1.79%)

07:32
11/22/19
11/22
07:32
11/22/19
07:32
Upgrade
HMS Holdings rating change  »

Guggenheim upgrades HMS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBWTF

Auxly Cannabis

$0.00

(0.00%)

07:31
11/22/19
11/22
07:31
11/22/19
07:31
Earnings
Auxly Cannabis reports Q3 EPS (C$0.03) vs. (C$0.02) last year »

Reports Q3 revenue C$1.6M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXE

Anixter

$85.30

-0.41 (-0.48%)

07:30
11/22/19
11/22
07:30
11/22/19
07:30
Hot Stocks
Anixter, CD&R announce amendment to up merger consideration to $82.50 per share »

As previously announced,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTSH

Cognizant

$63.42

-0.09 (-0.14%)

07:28
11/22/19
11/22
07:28
11/22/19
07:28
Downgrade
Cognizant rating change  »

Cognizant downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBS

Emergent BioSolutions

$52.46

-1.9 (-3.50%)

07:27
11/22/19
11/22
07:27
11/22/19
07:27
Recommendations
Emergent BioSolutions analyst commentary  »

Cantor reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$47.17

1.2 (2.61%)

07:27
11/22/19
11/22
07:27
11/22/19
07:27
Periodicals
Sanofi EVP in charge of strategy leaving by end of month, Reuters says »

Muzammil Mansuri,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

NXRT

NexPoint Residential

$47.61

-0.49 (-1.02%)

07:27
11/22/19
11/22
07:27
11/22/19
07:27
Initiation
NexPoint Residential initiated  »

NexPoint Residential…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APLS

Apellis

$28.49

-0.15 (-0.52%)

07:26
11/22/19
11/22
07:26
11/22/19
07:26
Initiation
Apellis initiated  »

Apellis has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

KKR

KKR

$29.07

-0.25 (-0.85%)

07:26
11/22/19
11/22
07:26
11/22/19
07:26
Periodicals
KKR gets halfway in $3B Asia infrastructure fundraising, Reuters says »

According to Reuters, KKR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDHL

RedHill Biopharma

$5.70

-0.21 (-3.55%)

07:25
11/22/19
11/22
07:25
11/22/19
07:25
Conference/Events
RedHill Biopharma to host investor & analyst day »

Investor & Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

BXRX

Baudax Bio

$4.66

-0.59 (-11.24%)

07:24
11/22/19
11/22
07:24
11/22/19
07:24
Initiation
Baudax Bio initiated  »

Baudax Bio initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$53.89

1.41 (2.69%)

07:23
11/22/19
11/22
07:23
11/22/19
07:23
Initiation
Biohaven Pharmaceutical initiated  »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$56.84

0.455 (0.81%)

07:23
11/22/19
11/22
07:23
11/22/19
07:23
Initiation
Bristol-Myers initiated  »

Bristol-Myers resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ENR

Energizer

$49.05

1.33 (2.79%)

07:22
11/22/19
11/22
07:22
11/22/19
07:22
Recommendations
Energizer analyst commentary  »

Energizer Analyst Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,734.99

-10.51 (-0.60%)

, MSFT

Microsoft

$149.46

-0.14 (-0.09%)

07:20
11/22/19
11/22
07:20
11/22/19
07:20
Periodicals
Amazon suit to likely delay start of Pentagon technology program, Bloomberg says »

Amazon (AMZN) could…

AMZN

Amazon.com

$1,734.99

-10.51 (-0.60%)

MSFT

Microsoft

$149.46

-0.14 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 04

    Dec

  • 09

    Dec

ABCB

Ameris Bancorp

$42.81

-0.4 (-0.93%)

07:19
11/22/19
11/22
07:19
11/22/19
07:19
Recommendations
Ameris Bancorp analyst commentary  »

Ameris Bancorp subpoena…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

BWEN

Broadwind Energy

$1.44

-0.06 (-4.00%)

07:18
11/22/19
11/22
07:18
11/22/19
07:18
Hot Stocks
Broadwind Energy receives first solar market order »

Broadwind Energy has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASTC

Astrotech

$1.51

-0.06 (-3.83%)

07:18
11/22/19
11/22
07:18
11/22/19
07:18
Hot Stocks
Astrotech says 1st Detect sells TRACER 1000s to shipping & logistics company »

Astrotech Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGS

Medigus

$1.76

(0.00%)

07:17
11/22/19
11/22
07:17
11/22/19
07:17
Hot Stocks
Medigus receives $1.2M payment as part of MUSE agreement in China »

Medigus announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXLG

Destination XL

$1.45

-0.02 (-1.36%)

07:16
11/22/19
11/22
07:16
11/22/19
07:16
Hot Stocks
Breaking Hot Stocks news story on Destination XL »

Destination XL to close…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

T

AT&T

$37.59

0.415 (1.12%)

07:15
11/22/19
11/22
07:15
11/22/19
07:15
Recommendations
AT&T analyst commentary  »

AT&T near-term short…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 29

    Jan

DXLG

Destination XL

$1.45

-0.02 (-1.36%)

07:15
11/22/19
11/22
07:15
11/22/19
07:15
Hot Stocks
Destination XL expects FY19 free cash flow to be breakeven »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.